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ABSTRACT 
 
Traffic-related air pollution (TRAP) contributes significantly to overall ambient air 
pollution, and exposure to TRAP has been implicated in the development of an array of 
disease states, including asthma, chronic obstructive pulmonary disease (COPD), and 
lung cancer. TRAP exposure in utero and in early childhood can induce heritable 
epigenetic alterations. Additionally, in utero and early life TRAP exposure is linked to 
cognitive impairment, reduced lung function, asthma susceptibility, small for gestational 
age, and preterm birth. Furthermore, the risk of negative health outcomes increases with 
small incremental increases in particulate matter (PM) concentrations. Currently, many 
epidemiologic studies examining air pollution exposure in general or during pregnancy 
use sophisticated modeling to map exposure, or active air monitors for brief (24 to 48 
hours) exposure assessments and use these findings to extrapolate study populations  
exposure across a lifetime or the course of pregnancy. Furthermore, the EPA utilizes 
stationary monitors, with limited coverage, to measure air quality and identify regions 
that fail to meet Air Quality Index (AQI) Standards. This study was conducted to assess 
the effect of microenvironment on TRAP exposure among pregnant women, a 
susceptible population, in a region with high childhood asthma incidence, Hidalgo 
County, Texas. Women were equipped with active air monitors and GPS devices for three 
separate 24-hour time points to examine the role the microenvironment has on PM 
exposure as well as examine variation between participants and between sampling 
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points. Participants’ exposure was found to be highly variable and average PM2.5 ranged 
from almost nonexistent, at 1.92µg/m3, to unhealthy, at 126.7µg/m3. Over 82% of 
participants experienced exposure outside of the “Good” range set by the EPA, and 
almost a quarter of participants experienced PM2.5 exposure considered “Unhealthy” by 
the EPA. These results are intriguing given that these participants reside in a region that 
regularly falls into the “Good” AQI category. Moreover, for this population, the home 
microenvironment was the dominant microenvironment experienced and the largest 
single contributor to overall PM2.5 exposure. This study speaks to the inherent variability 
associated with measuring PM in a population and the need for refined measures of 
exposure that capture microenvironment variation.  
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NOMENCLATURE 
1-AP   1-Aminopyrene 
1-OHP   1-Hydroxypyrene 
1-NP 1-Nitropyrene 
B[a]P Benzo[a]pyrene 
µg/m3 Micrograms per meter cubed 
ng/m3 Nanograms per meter cubed 
OHNAAP Hydroxy-N-acetyl-aminopyrene 
OHNP Hydroxy-nitropyrene 
PAC Polycyclic Aromatic Compound 
PAH Polycyclic Aromatic Hydrocarbon 
pg/m3 Picograms per meter cubed 
PM2.5 Particulate matter >2.5µm in aerodynamic diameter 
TRAP Traffic-related air pollution 
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1.  INTRODUCTION 
 
Section 1.1 Air Pollution Overview 
Air pollution is a pervasive environmental health problem that contributes greatly to 
global morbidity and mortality. Broadly defined, air pollution is any form of 
contamination, physical, chemical or biological that alters the natural composition and 
properties of the atmosphere (WHO, 2014). Ambient air pollution is a complex chemical 
mixture produced by a wide range of activities and sources, both anthropogenic and 
natural, and includes compounds in the gaseous and particulate phases. The particulate 
phase consists of aerosolized solid and liquid phase compounds and represents the most 
hazardous constituent of ambient air pollution due to its association with several 
negative health effects (WHO, 2013). Particulate matter (PM) is classified by the 
aerodynamic diameter of the particle. Particles with a diameter between 10 µm and 2.5 
µm are designated as coarse particulate matter or PM10, and particles with a diameter 
less than 2.5 µm are designated as PM2.5 or fine particulate matter. PM2.5 represents a 
significant health threat because its small size allows penetration deep into the lung into 
the gas-exchange region where the compounds associated with PM2.5 can readily cross 
into the blood stream (Pinkerton et al., 2000; WHO, 2013). PM2.5 exposure has been 
strongly linked to acute and chronic illnesses, including asthma, chronic obstructive 
pulmonary disease (COPD), lung cancer, and cardiovascular disease. Annually, over 3 
million deaths are attributable to PM2.5 exposure (Lim et al., 2013; WHO, 2012; WHO, 
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2013). Additionally, PM2.5 exposure during fetal development and early life has been 
correlated with decreased birth weight, preterm birth, delays in cognitive development, 
and insulin resistance (Hyder et al., 2014; Pereira, Belanger, Ebisu, & Bell, 2014; Thiering 
et al., 2013; Yorifuji, Kashima, Higa Diez, Kado, & Sanada, 2016). 
 
Section 1.2 Traffic-related Air Pollution, PAHs and PACs 
PM2.5 is composed of a heterogeneous mixture of many compounds adhered to a 
carbonaceous core; the composition can vary greatly based on location and source (Ji & 
Hershey, 2012; U.S. Environmental Protection Agency, 2004). Constituents include 
metals, ammonium, sulfate, nitrate, elemental carbon, and organic carbon. Organic 
carbon represents a major portion and contains a large class of incomplete combustion 
byproducts, namely polycyclic aromatic hydrocarbons (PAHs). PAHs are a group of over 
one hundred chemicals composed of fused benzene rings (containing carbon and 
hydrogen atoms), many of which are toxic and carcinogenic (WHO, 2013). These 
compounds are ubiquitous in the environment, resulting from power plant and other 
industry emissions, biomass smoke, cigarette smoke, and vehicular exhaust. Polycyclic 
aromatic compounds (PACs) include additional compounds formed during incomplete 
combustion reactions, or PAHs that have further reacted in the atmosphere, such as 
nitrated or oxygenated PAHs. These PACs have been suggested to possess increased 
mutagenicity and toxicity and may be produced at higher concentrations in vehicle 
exhaust (Schuetzle, Riley, Prater, Harvey, & Hunt, 1982). In the U.S., the greatest single 
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contributor to ambient particulate matter pollution is traffic-related emissions, with 
diesel engine exhaust contributing a significant proportion (Hodan & Barnard, 2004; 
Woghiren-Akinnifesi, 2013) Therefore, traffic-related air pollution (TRAP) represents a 
significant source of pollution, particularly for susceptible groups like children, 
asthmatics, pregnant women, and immunosuppressed individuals.  
Despite the vast amount of epidemiological data that indicates exposure to PM2.5 
and PAHs in utero or during early childhood increases the risk of negative health 
outcomes, such as low birth weight, respiratory infection, asthma, and allergic disease, 
there are still major gaps in our understanding of interplay between PM2.5 and PAH/PAC 
exposure and health effects later in life (Bowatte et al., 2015; Hyder et al., 2014; 
Jedrychowski et al., 2013; Perera et al., 2009). Furthermore, as traffic emissions 
represent a prominent source of PAHs and PACs, the health effects of traffic-related air 
pollution (TRAP), need to be explicitly explored, especially in light of growing evidence 
that implicates exposure to TRAP in utero as a risk factor for asthma later in life (Clark et 
al., 2010; Nishimura et al., 2013; Zhou et al., 2013).  
In order to delineate the effects of TRAP exposure on health outcomes, TRAP 
should be quantified in a selective and sensitive manner. Furthermore, efforts to quantify 
exposure to TRAP should be robust enough to capture microenvironment variation, as 
macro-level estimations utilizing regression models and stationary monitors may not 
sensitive enough to identify the variation that occurs throughout a day, as individuals 
move from their residence, to their schools, places of work and other sites of variable 
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exposure. In order to conduct robust risk assessments for health effects of TRAP 
exposure, biomarkers of exposure are of critical need. The heterogeneous nature of 
TRAP complicates the ability to accurately measure exposure, as TRAP is a diverse and 
fluctuating mixture of hundreds to thousands of compounds. Thus, rather than attempt 
to measure this vast array of compounds, a surrogate or series of surrogates have been 
used as proxies for overall TRAP exposure. Several commonly used markers of TRAP 
include elemental carbon, total carbon, and overall PM2.5 concentration. Measurements  
of PM2.5 are convenient because they can be measured in real time and offer a metric 
that can be readily compared. Several studies have established a dose dependent 
association with PM2.5 and negative outcomes, with incremental increases of 10µg/m3 of 
PM2.5 associated with significantly increased risk of myocardial infarction, asthma 
symptoms, and overall mortality, as well as small for gestational age and low birth weight 
when exposed during pregnancy (McCormack et al., 2009; Shi et al., 2016; Stieb et al., 
2016; WHO, 2013). Despite the utility of PM2.5 measurements, these metrics alone are 
not effective as a biomarker because PM2.5 cannot be reliably calculated into a relevant 
dose of PAHs. Furthermore, due to the variable nature of PM2.5, exposure to the same 
concentration of PM but from different sources is likely to result in exposure to different 
compounds and perhaps differential toxicity.  
The measurement of PAHs is one method to look at dose of exposure, and several 
PAHs have been classically used as proxies for the measurement of TRAP. Two of the 
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most regularly used PAH proxies are pyrene and benzo[a]pyrene (B[a]P) (Figure 1.1), 
which are PAHs present in high concentrations formed during incomplete combustion.  
 
 
Figure 1.1 Chemical structures of representative PAHs. Benzo[a]pyrene and 
pyrene have been used extensively as proxies for overall PAH exposure. 
 
Pyrene is ubiquitous in organic combustion emissions and generally occurs in high 
concentrations allowing for ease of detection. B[a]P is often used as a proxy for overall 
PAH carcinogenicity because it is a known human carcinogen (Jung et al., 2010; Perera, 
Tang, Whyatt, Lederman, & Jedrychowski, 2005). Furthermore, the exposure pathways, 
urinary metabolites of B[a]P and pyrene and half-lives are well characterized, allowing 
for researchers to measure concentrations in the environment, as well as at the 
individual level through metabolites in biological samples (Morgott, 2014). The urinary 
metabolite 1- hydroxypyrene (1-OHP) has been extensively characterized and validated 
as a biomarker of PAH exposure in many human populations and is widely accepted due 
to the presence of pyrene in most PAH mixtures (Morgott, 2014; Scheepers et al., 2004). 
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However, the use of 1-OHP, as well as B[a]P metabolites, to classify overall PAH exposure 
is not without limitation. Both pyrene and B[a]P are pervasive in the emissions of other 
organic fuels. This can pose a significant barrier to measuring TRAP in the presence of 
other PAH sources such as industrial emissions, cigarette smoke, and fires. Additionally, 
the metabolites of these compounds may fail to correlate with overall exposure or may 
be masked by other behaviors that contribute to PAH exposure, such as environmental 
tobacco exposure or the consumption of foods prepared by grilling, roasting, or broiling 
(Morgott, 2014). In fact, several researchers have called for more specific biomarkers of 
exposure to TRAP. Hara et al (1997) examined exposure to TRAP among city sanitation 
workers via personal air monitors and compared total diesel exhaust exposure to urinary 
1-OHP. Strikingly, the researchers did not identify a relationship between diesel exhaust 
exposure and 1-OHP and noted that 1-OHP may be an imperfect biomarker when 
attempting to quantify low level exposures, which are frequently encountered in 
ambient atmosphere (Hara, Hanaoka, Yamano, & Itani, 1997). Scheepers et al (2004) 
examined urinary 1-OHP in a population of shale miners and identified no significant 
difference in metabolite concentration between underground workers exposed to high 
levels of diesel exhaust versus aboveground workers (Scheepers et al., 2004). These 
results were surprising as the underground workers were exposed to levels of diesel 
exhaust at an order of magnitude greater than surface workers. Although other studies 
have effectively utilized 1-OHP as a marker of air pollution, the utility of 1-OHP as a 
specific biomarker marker of TRAP is limited, especially in the presence of other PAH 
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sources. To better examine exposure specific to TRAP, a biomarker must be used that 
correlates well with sources of TRAP and not simply general combustion (Morgott, 2014).   
Section 1.3 1-Nitropyrene  
One proposed biomarker of TRAP is 1-nitropyrene (1-NP) and its associated metabolites.  
1-NP is technically classified as a PAC and belongs to a class of compounds called nitrated 
polycyclic aromatic hydrocarbons (NPAHs). 1-NP is produced during incomplete 
combustion in the presence of atmospheric nitrogen and is composed of four peri-fused 
benzene rings with a nitro functional group (Figure 1.2).  
 
 
Figure 1.2 1- Nitropyrene structure. 
 
1-NP has been identified as genotoxic and mutagenic in several in vivo and in vitro 
models and is classified as a Group 2B carcinogen by the International Agency for 
Research on Cancer (IARC), “a substance possibly carcinogenic to humans” (IARC, 1989; 
National Toxicology Report, 1996; Salmeen, Durisin, Prater, Riley, & Schuetzle, 1982; 
Schuetzle et al., 1982). It also contributes greatly to the overall carcinogenicity of diesel 
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engine exhaust, a substance classified by the International Agency for Research on 
Cancer (IARC) as a Group 1 carcinogen, “a substance carcinogenic to humans” (IARC, 
2012).  
1-NP is the most common NPAH present in diesel engine exhaust and a very 
common NPAH in ambient atmosphere (Bamford, Bezabeh, Schantz, Wise, & Baker, 
2003; Rosenkranz, 1982). The amount of 1-NP found in the atmosphere can vary greatly 
and is dependent on traffic volume, temperature, season, and time of day. Ambient air 
in regions with dense traffic can contain 1-NP near or above 1 ng/m3; however, urban 
and suburban levels are usually measured in hundreds or tens of pg/m3. The lowest 
recorded levels are found in extremely remote regions and at levels in the low pg/m3 
range (IARC, 2013). Seasonal peaks occur during winter months with daily peaks 
coinciding with periods of increased traffic volume. The seasonal peaks are attributed to 
decreased sunlight, which in turn decreases the occurrence of photolytic degradation. 
Additionally, other variables can influence the concentration of 1-NP emitted by diesel 
engines, including engine efficiency, engine workload, fuel type, fuel age, and the 
presence of emissions controls (Schuetzle & Perez, 1983). 
1-NP has also been identified in the emissions of propane and liquefied 
petroleum gas, crankcase oils, and certain grilled or fried foods. Unlike other biomarkers 
of combustion that can originate as both primary emissions or form during secondary 
atmospheric reactions, 1-NP is not formed through the atmospheric reaction of pyrene 
with hydroxyl or NOX radicals (2- and 4-nitropyrene are the species formed instead) (Pitts 
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et al., 1978). Furthermore, 1-NP has not been identified in the mainstream or side stream 
smoke of cigarettes, a characteristic that expands the utility of this compound as a 
biomarker of TRAP (IARC, 2013). Thus, 1-NP has the potential to serve as a valuable 
biomarker of exposure to TRAP as the combustion of diesel fuel remains the foremost 
source of atmospheric 1-NP and skewing due to other sources like secondary 
atmospheric formation, environmental tobacco smoke, and fires is unlikely (Atkinson & 
Arey, 1994; IARC, 2013; Kielhorn, Wahnschaffe, Mangelsdorf, & International 
Programme on Chemical Safety, 2003; Wang et al., 2015).  
 
Section 1.4 1-Nitropyrene Metabolism 
The metabolism of 1-NP has been characterized in a variety of animal and cell models 
and major metabolites have been identified in rodents and humans (IARC, 2013; National 
Toxicology Report, 1996). Despite significant scientific investigation into 1-NP 
metabolism in rodent models, the current understanding of human 1-NP metabolism is 
limited. This is in part due to the fact that human exposure to 1-NP occurs concurrently 
with many other compounds in a diesel engine exhaust mixture. Nonetheless, the 
general schema of metabolism is understood. For the majority of the population it is 
expected that inhalation is the major route of exposure, with dermal exposure and 
ingestion also contributing to a lesser extent depending on personal behaviors. Upon 
inhalation, most 1-NP is rapidly cleared by the upper respiratory tract and absorbed into 
the bloodstream within an hour (National Toxicology Report, 1996).  Particle bound 1-NP 
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may also be caught in the upper respiratory system and then ingested via mucociliary 
clearance (J. D. Sun, Wolff, Aberman, & McClellan, 1983). From there, 1-NP enters the 
gastrointestinal tract and is rapidly absorbed into the blood stream (Van Bekkum, Van 
den Broek, Scheepers, Noordhoek, & Bos, 1999). Once in the bloodstream 1-NP is 
transported to the liver and kidneys and metabolized, with high levels of macromolecule 
binding occurring in both the kidneys and liver.   
Phase I metabolism occurs in one of two ways, nitroreduction or oxidation. The 
metabolic pathway undertaken is determined by available oxygen, with anaerobic 
conditions leading to nitroreduction and aerobic conditions favoring oxidation (El-
Bayoumy & Hecht, 1983). Additionally, the metabolic pathways are not exclusive, as a 
considerable portion of 1-NP metabolites are oxidized and then reduced.  Nonetheless, 
both of these pathways are biologically significant, and the metabolites formed via 
nitroreduction and oxidation can react with DNA forming adducts (Howard, Flammang, 
& Beland, 1985). Ring oxidation, which occurs under aerobic conditions, produces a 
range of hydroxy-1-nitropyrenes as well as K region nitropyrene epoxides (National 
Toxicology Report, 1996). These epoxides are deleterious as they are extremely unstable 
due to their high ring strain and are capable of covalently bonding with proteins as well 
as DNA; additionally these epoxides can also be further oxidized to form dihydrodiols 
(National Toxicology Report, 1996). Cytochrome P-450 (CYP) 3A3 and 3A4 specifically, 
were identified as the enzymes responsible for 1-NP metabolism in human microsomal 
samples as they were the only class of CYPs that exhibited catalytic activity towards 1-NP 
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(Silvers et al., 1992). However, other CYP enzymes may be involved in 1-NP metabolism 
as inhibition of CYP3A3 and 3A4 reduced 1-NP metabolism to 30-40%, but did not 
prevent it completely. Additional studies using human breast cells, immortalized breast 
cells, and immortalized breast epithelial cells have identified CYP 1A1 and 1B1 as 
enzymes capable of mononitropyrene metabolism with the potential of forming reactive 
metabolites capable of forming macromolecule adducts (Sun, Yuan-Wan Guengerich, F 
P Sharma, Arun Boyiri, Telih Amin,Shantu el Bayoumy, Karam, 2004).  
The other main phase I metabolic pathway of 1-NP, nitroreduction, has been 
observed in vivo and in vitro in a variety of animal systems and can be catalyzed by both 
mammalian enzymes such as xanthine oxidase, aldehyde oxidase, or DT-diaphorase as 
well as bacterial nitroreductases. The reduction of 1-NP is sequential and the metabolites 
formed in the process exhibit a broad range of properties. Metabolites such as 1-
aminopyrene (1-AP) are less toxic than 1-NP and do not appear to be mutagenic. 
Furthermore, 1-AP can be readily conjugated by phase II enzymes allowing for 
elimination (Manning, Cerniglia, & Federle, 1986). However, intermediates formed 
during the reduction of 1-NP to 1-AP, such as N-hydroxy-1-aminopyrene and 1-
nitrosopyrene can form adducts with DNA and proteins (King, Kohan, George, Lewtas, & 
Claxton, 1990). Research has demonstrated that both bacterial and mammalian cell lines 
can form DNA adducts during the nitroreduction of 1-NP (Edwards, Batmanghelich, 
Edwards, Parry, & Smith, 1986). Additionally, human umbilical cord vein endothelia 
exposed to low levels of 1-NP display DNA damage and increased production of reactive 
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oxygen species (ROS). However, when nitroreductase activity is inhibited, levels of DNA 
damage and ROS significantly decrease (Andersson, Piras, Demma, Hellman, & Brittebo, 
2009). These metabolic products of phase I enzymes are then metabolized by phase II 
enzymes, responsible for conjugating the newly oxidized or reduced compounds with 
glutathione, glucuronic acid, or sulfuryl groups forming metabolites that are readily 
excreted into the urine or into bile and then feces. (Jancova, Anzenbacher, & 
Anzenbacherova, 2010; Medinsky, Shelton, Shelton, & McClellan, 1985). However, a 
portion of 1-NP is reabsorbed, facilitated by intestinal bacteria (Medinsky et al., 1985). 
Enteric bacteria are believed to cleave the phase II conjugates allowing for secondary 
metabolism to occur (Kataoka, Kinouchi, Akimoto, & Ohnishi, 1995). Wild type mice 
administered 1-nitropyrene epoxides, already conjugated to glutathione, form DNA 
adducts whereas antibiotic treated mice do not (Kinouchi, Kataoka, Miyanishi, Akimoto, 
& Ohnishi, 1993). Furthermore in vitro studies have shown a variety of bacterial β-lyases 
are capable of transforming 1-nitropyrene epoxide conjugates into mutagenic and 
biologically active compounds (Kataoka et al., 1995). The compounds are then 
recirculated and can be nitroreduced through human or bacterial enzymatic processes. 
In addition to contributing to 1-NP secondary uptake, enteric bacteria are believed to 
have a substantial role in the metabolism of 1-NP in mammals. Human, mouse and rat 
intestinal flora have all been shown to reduce 1-NP to 1-AP, as well as other minor 
nitroreduction products (King et al., 1990). Furthermore, the formation of 1-NP 
metabolites, primarily 1-AP, is greatly reduced in antibiotic-treated or germfree animals.  
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In one study, in which germ free and conventional rats were treated with 1-NP via oral 
gavage, no detectable amount of 1-AP was identified in the feces of germ free rats, 
however 1-AP was found in the feces of conventional rats (El-Bayoumy, Sharma, Louis, 
Reddy, & Hecht, 1983). A separate study compared the formation of 1-NP metabolites 
and metabolite binding in the lung and liver of antibiotic treated rats and conventional 
rats. Antibiotic treated rats displayed significantly lower metabolite binding in the lung 
when compared to control animals. Additionally, control animals displayed greater 
amounts of 1-AP and 1-acetylaminopyrene than the treatment group, illustrating the 
potential role enteric bacteria play in 1-NP reduction (Ayres, Sun, & Bond, 1985). 
Furthermore, human fecal bacteria treated with 1-NP are capable of reducing the 
compound to 1-AP, an indication that unaltered 1-NP in feces can still be reduced within 
the lower gastrointestinal tract. These studies point to the intricate relationship that 
mammalian microbiota is believed to play in 1-NP metabolism and the likely variation 
expected due to the complexity and variation seen in human microbiota (Mentis, Gypas, 
& Mentis, 2013).  
 
 
 14 
 
Figure 1.3 Biologically significant metabolites of 1-nitropyrene. 
 (From left to right): Top: 1-nitropyrene-4,5-oxide, 1-nitropyrene-trans-4,5-
dihydrodiol, 1-aminopyrene. Middle row: 3-hydroxy-1-nitropyrene, 6-hydroxy-1-
nitropyrene, and 8-hydroxy-1-nitropyrene. Bottom row: 3-hydroxy-N-acetyl-1-
aminopyrene, 6-hydroxy-N-acetyl-1-aminopyrene, and 8-hydroxy-N-acetyl-1-
aminopyrene. 
 
The assessment of 1-nitropyrene metabolites in humans is a recent development 
and has been limited to a handful of studies. Toriba et al (2007) was the first to examine 
a range of 1-NP metabolites in human urine and identified 3-, 6-, and 8-hydroxy-1-
nitropyrene (3-, 6-, and 8-OHNP) and 3-, 6-, and 8-hydroxy-N-acetyl-1-aminopyrene (3-, 
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6-, and 8-OHNAAP) as the major metabolites (Figure 1.3). Researchers reported that 
unlike in animal models, OHNPs were the predominant human metabolites and that the 
6- and 8- position OHNPs and OHNAAPs were preferentially formed over the 3- position 
metabolites (Toriba et al., 2007a). 
Miller-Schulze et al. (2013) identified three metabolites (6-, 8-OHNP, and 8-
OHNAAP) consistently in an exploratory study among Chinese taxi drivers, however the 
authors did not identify a significant increase in metabolite concentration after elevated 
occupational 1-NP exposure (Miller-Schulze et al., 2013). The sampling time points used 
may have complicated the relationship between exposure and metabolite elimination. 
The authors estimated that the half-lives of the OHNP and OHNAAP metabolites are 
roughly 10 to 12 hours. As such, their urine sampling times may have missed the peak 
excretory point. Laumback et al. (2009) examined urinary concentrations of 1-AP in spot 
urine samples from human volunteers who were exposed to 60 minutes of clean filtered 
air and 60 minutes of diluted diesel exhaust in a controlled exposure chamber at least a 
week apart. In this study, the majority of subjects had higher 1-AP levels in their urine 
following exposure to diesel exhaust when compared to clean filtered air. However,  
significant variation between subjects was observed which made it difficult for the 
authors to draw major conclusions from the results. A secondary analysis identified 
variation in the rate of 1-AP excretion between subjects, with one group reaching peak 
excretory levels at roughly 5.5 hours after exposure and the other group believed to have 
a peak excretory value beyond the 24 hour period of the study (Huyck et al., 2010). 
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Galaviz (2013) examined 1-nitropyrene exposure and two 1-NP urinary metabolites (8-
OHNP and 8-OHNAAP) among individuals who regularly commuted across the California-
Mexico border as well as those who did not commute across but lived proximal to the 
border. Border commuters, the high exposure group, were found to be significantly 
exposed to more PM2.5, and 8 times more 1-NP than those who did not commute across 
the border.  Furthermore, the urinary concentration of 8-OHNP and 8-OHNAAP were two 
and three times higher, respectively, than their non-commuting counterparts (Galaviz, 
2013). This research in this thesis draws upon the growing body of human 1-NP exposure 
assessment with the goal of exploring the use of 1-NP as a biomarker of TRAP in pregnant 
women residing in Hidalgo County.  
Section 1.5 Study Rationale and Aims 
Air pollution represents a severe and growing environmental problem along the U.S.-
Mexico Border, as this dynamic region has experienced rapid population growth and 
development in the past 30 years. The U.S. border population has increased by 5 million 
from 1980 to 2005 and is expected to double within 30 years, as economic conditions 
have favored increased industrial expansion and trade between the U.S. and Mexico. This 
increase in industry, population, and trade has led to an increase in many environmental 
issues, including air pollution (Lee et al., 2013). Emissions of fine particulate matter in 
Hidalgo County, TX (our study location) have continuously risen.  Childhood asthma is an 
emerging as a priority public health problem in Hidalgo County where rates are 
significantly higher than the overall state rate (11.4% versus 7.4%) and hospitalization 
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rates are 50.5% higher than the state average. The link between air pollution exposure 
during critical developmental windows, namely, prenatal or early infancy periods, and 
the development of childhood asthma has become increasingly accepted, however has 
yet to be explored as a potential etiologic factor in this region. Moreover, the lack of 
validated individual exposure biomarkers has limited knowledge of PAHs/PACs on 
asthma risk following prenatal air pollution exposure.   
Therefore, the primary research objective of this project was to characterize 
prenatal exposure to traffic-related air pollution in women living in Hidalgo County, 
where the rates of childhood asthma are some of the highest in the state, and investigate 
the potential for 1-NP metabolites to serve as biomarkers of exposure to TRAP. The focus 
of this thesis is on the characterization of prenatal exposure through the following 
specific aims: 
Aim 1. Our first aim was to utilize traditional active air sampling techniques to 
assess personal PM2.5 exposure in women recruited in their third trimester of pregnancy 
from prenatal clinics in the McAllen-Edinburg urban area.  
Aim 2. The second aim was to investigate the contribution of various 
microenvironments to overall  PM2.5 exposure. 
Future work in this population will focus on measuring individual PAH and NPAH 
urinary metabolites, 1-OHP, 3-,6-, and 8-OHNP, and 3-,6-, and 8-OHNAAP, and compare 
levels with personal PM2.5 exposure metrics.  
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2.  METHODS 
 
Section 2.1 Population 
Hidalgo County is located in the Southern tip of Texas, along the U.S.-Mexico border and 
close to the Gulf of Mexico. Hidalgo County contains the McAllen-Edinburg-Mission 
Metropolitan Statistical Area, and is home to over 842,000 residents. Hidalgo County is 
also a very young region, with roughly 33% of residents under the age of 18. Additionally, 
the region experienced an 8.7% population increase from 2010 to 2015, over twice as 
fast as the national average (US Census Bureau, 2015). At over 90% percent, the vast 
majority of residents are Hispanic or Latino and 85% of residents speak a language other 
than English at home (US Census Bureau, 2015). The major economic activities are 
centered on agribusiness, agriculture, food processing, tourism, and petroleum (Garza, 
2010). The county is also considerably more impoverished than the national or state 
average, as the median household income for the county was $34,952 in 2014, and 
roughly 33% of the population is in poverty.  
 
Section 2.2 Study Participants 
Participants (n = 18) were recruited in local prenatal health clinics by medical assistants 
and community health workers. Eligibility criteria required that participants be: 21 to 35 
years of age, nonsmokers residing with nonsmokers, in their third trimester of pregnancy 
at time of sampling, current residents of Hidalgo County, and planning to deliver at the 
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Rio Grande Regional Hospital in McAllen. Potential candidates for participation were 
screened by clinic staff at the regional clinics where they were receiving prenatal care. 
Viable candidates were introduced to the study by clinic staff, and if they expressed 
interest local community health workers contacted them to further explain the study 
process and provide informed consent (IRB2014-0813F).  
 
Section 2.3 Overall Study Design 
The study design involved repeated measures consisting of three separate sampling 
points occurring at 2-week intervals. At the time of consent or at the first sampling time 
point each participant was administered a questionnaire detailing personal behaviors, 
home and work environment, and lifestyle factors related to traffic exposure. At each 
sampling time point, the participants were provided with air sampling equipment in a 
small backpack by a community health worker and instructed to wear the backpack or 
keep the backpack in their breathing zone for 24 hours. This backpack contained an active 
air monitor, as well as a GPS device, and a humidity and temperature logger. The 
following day the participant’s first morning urine void was collected along with the 
backpack and returned to the community health worker. The third (and final) sampling 
point included the collection of a hair sample and a venous blood draw at a prenatal 
wellness clinic. At the end of each 24-hour sampling period, a 24-hour questionnaire was 
administered to the participants, which detailed the activities conducted in the past day.  
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Section 2.4 Air Pollution Exposure Assessment  
At two-week intervals participants were delivered a portable air monitor in a small 
backpack and asked to wear it or keep it near breathing level for 24 hours. After 24 hours 
a community health worker collected the air monitor and delivered it to the field 
laboratory. The air sampling equipment contained in the backpack (Figure 2.1) consists 
of an active nephelometer (personal data ram pDr 1000, Thermo Scientific) that detected 
PM2.5 in real time and logged measurements at 10 second intervals. In order to size select 
for PM2.5 the pDr’s inlet was equipped with a 2.5 µm impactor connected to a sampling 
pump (Omni-400 personal sampling pump, BGI by Mesa Labs) operated at a continuous  
flow rate of 4L/minute with the PM2.5 collected on 37mm pre-weighed Teflon filters. A 
second line from the BGI pump was split to draw air at 1L/minute through a 37mm PTFE 
filter (Zefluor™ Supported PTFE, Pall Corporation #28139-222) for PAH and 1-NP analysis, 
followed in line by a XAD resin tube (XAD-2 p-asinidine, SKC Inc. # 226-30-07) for volatile 
PAH analysis. Sampling pumps and inlets were calibrated before and after each 24 hour 
sampling period and averaged after each run.  After the end of each 24 hour sampling 
period the Teflon filter, PTFE filter, and XAD tube were removed from the monitor, placed 
in individual plastic petri dishes, bagged and stored at -20°C. The PM2.5 data was then 
downloaded immediately after each sampling period along with temperature and 
humidity (HOBO data logger, UX100-003) and GPS data (Qstarz International, BT-
Q1000XT).  
 21 
 
 
Figure 2.1 Sampling backpack and contents. Sampling inlets for PTFE filter (with red 
wrap) and for Teflon filter are visible outside of the backpack. The pDr and pump are 
contained within the backpack.  
 
The Teflon filters were weighed on a microbalance with 1-μg resolution in a temperature 
and humidity controlled room. Total mass of PM2.5 was calculated by comparison with 
the original filter mass.  
 
Section 2.5 Urine Collection & PAH/PAC Metabolite Analysis  
Participants were provided with a sterile 120 ml plastic urine container (BD Vacutainer 
Urine Collection Cup, #364975) and instructed to collect their first morning void upon 
waking the next day. Participants were then instructed to keep urine cool until transport 
on ice to the field laboratory by a community health worker. Upon receipt of urine, the 
volume was measured and recorded. Next, deionized water was added until the final 
volume reached 100 ml. The urine was then partitioned into a 5ml aliquot for creatinine 
analysis (Baylor Scott and White Healthcare), with the remainder stored in polypropylene 
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50 ml Falcon tubes. All urine was stored at -20ºC at the field laboratory until transported 
on dry ice and stored at -80°C until sample analysis in our laboratory in College Station.  
Urine was thawed and 5 ml 4M sodium acetate buffer was added, followed by 
75µl 1M HCl to adjust to pH 5. Deuterated internal standards, were synthesized, as 
described below, according to Toriba et al (2007), Rosser et al (1996) and 
Abe, Y., & Saito, M. (1965), and spiked into the urine and incubated with 75 µL β-
glucuronidase/aryl sulfatase at 37°C for 4 hours in a shaking water bath in order to 
deconjugate the PAC metabolites. Upon deconjugation, the urine was incubated with 
100g blue rayon for 1 hour at room temperature while in a orbital shaker at 60 rpm. The 
blue rayon was then transferred to a funnel and rinsed with deionized water and then 
dried in an empty 20 cc Sep-Pak cartridge. The dried blue rayon was then sonicated in 20 
mL methanol: ammonium (50:1) for 30 minutes while protected from light. This solution 
and the subsequent methanol rinses of the blue rayon were filtered and blown down 
under nitrogen to dryness using a TurboVap. The extract was then dissolved in 5 mL ethyl 
acetate: methanol; (1:1), vortexed and then eluted through a Sep-Pak Alumina A 
cartridge. The extract was collected and reduced to dryness under nitrogen and then 
suspended in 300 µl methanol until analysis using LC-MS/MS.  
 
  
 
 
 23 
 
Section 2.6 Metabolite Standard Synthesis 
Briefly, 5.002 g pyrene was acetoxylated via reflux with 11.027 g lead (IV) acetate in 30 
ml 9:1 toluene: acetic acid for 6 hours at 80ºC. The resulting product was separated via 
column chromatography using 10% ethyl acetate: hexane as the elutant. The 
acetoxypyrene eluted as the second bright blue band when visualized with long wave UV 
light. This was collected and dried under nitrogen. The acetoxypyrene was then nitrated 
following the procedure outlined by Abe, Y., & Saito, M. (1965) with minor revisions, 
briefly 1 g acetoxypyrene was dissolved in 8ml glacial acetic acid while lightly stirring at 
45ºC and then nitrated with 0.9 ml concentrated nitric acid. The solution turned dark red 
and acetoxynitropyrene precipitated out as bright yellow precipitate. The 
acetoxynitropyrene was filtered, dried under nitrogen. To deprotect the 
acetoxynitropyrene, the compounds were dissolved in 4% sodium hydroxide. When the 
solution turned deep purple the liquid was filtered and then concentrated hydrochloric 
acid was added dropwise until the solution turned acidic, as monitored by pH paper. 
Upon acidification, the solution turned bright red and then clear as red 
hydroxynitropyrene precipitated out. The precipitated was filtered, washed, and dried 
under nitrogen. Hydroxy-N-acetyl-1-aminopyrene utilized the hydroxypyrenes as the 
precursor. These were dissolved in methanol, with Raney Copper and sodium 
borohydride, stirred at 40ºC and then filtered into acetic anhydride. Nitropyrene was 
synthesized following the nitration protocol from Abe, Y., & Saito, M. (1965), however 
using pyrene as the precursor instead of acetoxypyrene. Hydroxypyrene utilized the first 
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step of hydroxynitropyrene synthesis, however skipped the nitration step and proceeded 
directly to deprotection. Deuterated standards were synthesized following the same 
protocols, using deuterated d10-pyrene as the precursor.  
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3. RESULTS 
 
Section 3.1 Summary 
A total of 17 participants were sampled, resulting in 50 independent sampling events 
(one participant was unable to complete the third sampling run). Average exposure to 
PM2.5 was quite variable between participants and between sampling time points, as 
seen in Table 3.1 and Figure 3.1. Furthermore, participants’ exposures were quite 
variable between home and commute. 
Table 3.1 Summary Statistics of PM2.5 Sampling Events 
PM2.5 Summary Statistics 
N: 50   
Mean: 26.06 µg/m3 
Lowest 
Value 
1.92 µg/m3 
Median: 17.22 µg/m3 
Highest 
Value 
126.74 µg/m3 
Standard 
Deviation: 
29.07 Range 124.82 µg/m3 
 
When compared to the U.S. EPA Air Quality Index (EPA AQI) (Table3.2), a majority of 
participants, over 82% (14/17), had at least one day at which their PM2.5 exposure was 
above the EPA Air Quality Index Category “Good”. Furthermore, almost a quarter of 
participants (4/17) has at least one day at which their air pollution exposure was 
considered “Unhealthy” per the EPA AQI standards.  
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Table 3.2 U.S. EPA Air Quality Index Categories 
Air Quality Index 
Category 
PM2.5 24 hour 
Average in µg/m3 
Good 0.0 – 12.0 
Moderate 12.1 – 35.4 
Unhealthy for 
Sensitive Groups 
35.5 – 55.4 
Unhealthy 55.5 – 150.4 
Very Unhealthy 150.5 – 250.4 
Hazardous 250.5+ 
 
 
Figure 3.1 24-hour average PM2.5 exposure by sampling point. 
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 Section 3.2 Sources of PM2.5 
The sources of PM2.5 were diverse and were categorized into the following 
microenvironments: home, work, time in a vehicle, and other, based on GPS data and 
time activity diaries. When stratified by microenvironments, the majority of sampled 
time occurred at home, however across sampling events, time at home ranged from 45% 
to almost 100% (Figure 3.2). These microenvironment patterns were generally consistent 
across each participant’s sampling cluster (Figure 3.3). Work microenvironments were 
only identified in two participants and time in vehicle differed greatly among 
participants.  When the contribution of these microenvironments to cumulative PM2.5 
mass was examined, PM2.5 exposure from home was found to contribute overwhelmingly 
to cumulative PM2.5 mass (Figure 3.4), with the exception of three sampling runs in which 
time in vehicle, work, and other, respectively, exposure contributed to the majority of 
cumulative PM2.5 mass. 
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Figure 3.2 Percent of sampling time spent in microenvironment. 
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Figure 3.3 Percent contribution of microenvironment to total PM2.5 mass. 
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Figure 3.4 Cumulative mass concentration by microenvironment. 
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Section 3.3 Comparison to TCEQ Air Monitor 
Participants active air monitor 24 average was compared to the Texas Commission on 
Environmental Quality (TCEQ) air monitor for the same intervals , the summary statistics 
of these sampling events are listed in Table 3.3. When compared via two-sided T-test 
with unequal variance no significant difference between the two sampling events was 
identified. 
Table 3.3 Summary Statistics of TCEQ PM2.5 Sampling Events 
TCEQ PM2.5 Summary Statistics 
N: 50   
Mean: 28.45 µg/m3 
Lowest 
Value 
1.93 µg/m3 
Median: 17.83 µg/m3 
Highest 
Value 
164.15 µg/m3 
Standard 
Deviation: 
33.93 Range 162.23 µg/m3 
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4.  CONCLUSIONS 
 
Air pollution exposure assessment is often a tradeoff between achieving coverage and 
identifying the intricacies of exposure. As air pollution exposure can vary greatly 
spatiotemporally, the role of one’s microenvironment is a major factor in overall 
exposure, as TRAP levels have been shown to fluctuate even across relatively small 
distances (Ryan & LeMasters, 2007). Efforts to model air pollution exposure based on 
single 24 or 48 hour exposure windows may misclassify exposure due to variability 
between days, especially if the sampling period captures a rare contributor to air 
pollution, like an haze event or higher than normal time in a vehicle, or misses  a regular 
contributor to air pollution that occurs outside of the sampling period. Furthermore, 
weather, seasonal variation, and alterations in personal behaviors can all contribute to 
the complexity of accurately assessing air pollution exposure. This study examined the 
utility of three, 24-hour time points, each roughly 2 weeks apart, to explore the role of 
the microenvironment on PM2.5 exposure among pregnant women. Not surprisingly, the 
women sampled exhibited diverse exposures and unique microenvironments, which 
directly impacted their exposure. Home was the largest contributor to PM2.5 mass which 
is understandable due to the large amount of time spent in the home microenvironment. 
In this population, however, it was postulated that traffic may be a major source of PM2.5 
due to the proximity of the study site to three major border crossings, which in total 
experienced a traffic volume of 546,259 heavy trucks, 25,776 buses, and 4,594,298 
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personal vehicles crossing into the U.S. in 2015 alone (US Department of Transportation, 
2016). Despite the high volume of traffic nearby, the overall burden of PM came from 
the home environment, however, the source of the PM will have to be analyzed, 
comparing markers of TRAP to markers of general combustion before the amount of 
traffic derived particulate can be determined.   
Also of note is the relationship between 24 hour PM2.5 averages and the EPA Air 
Quality Index Standards. The majority of women (over 82%) experienced at least one day 
where their 24-hour sampling period was classified as less than good. This seemingly 
small increase in PM exposure is not without its risks as several studies have identified 
strong relationships between increases of PM2.5 in 10 µg/m3 increments and significantly 
increased risk of small for gestational age and low birth weight when exposed during 
pregnancy, as well as increased risk myocardial infarction, asthma symptoms, and overall 
mortality (McCormack et al., 2009; Shi et al., 2016; Stieb et al., 2016; WHO, 2013). 
Unfortunately, small for gestational age and low birth weight put children at increased 
risk of stillbirth and early mortality as well as obesity, metabolic disease, diabetes, and 
myocardial infarction later in life (Curhan et al., 1996; McCowan et al., 2010). As such, 
even seemingly minor increases in PM2.5 should be viewed as an increase in risk and 
efforts should be made to reduce overall exposure, especially among pregnant woman 
and other susceptible groups. Roughly 23% of the women sampled reached levels 
deemed unhealthy by the EPA and in particular about 10% of the participants had 
consistently high PM exposures across their sampling cluster. These individuals represent 
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a population that warrants additional research and a potential intervention, as 
mentioned earlier their high exposure levels put them and their children at increased risk 
of negative health outcomes and thus even moderate reductions in PM exposure would 
reduce their risk of negative outcomes later in life. 
Also of interest was the success of the TCEQ air monitor at measuring fairly 
consistent PM data in relation to the active air monitors. It was postulated that the TCEQ 
monitor would be less accurate than the active air monitor due to the air monitor’s  
proximity to the participant. In some cases the TCEQ monitor over or under estimated 
participants exposure, but 68% of the sampling events the monitor was within 5% of the 
active air monitor values. This strong association seems to indicate that a significant 
amount of PM that the participants are exposed to is from the ambient environment, 
however, additional investigation is warranted to measure both the source of the PM 
and the reliability between the stationary monitor and the active air monitors.  
The current state of air pollution exposure assessment is hampered by the 
variable nature of air pollutants and the impact of microenvironments on exposure. 
Additionally, although risk of health effects can be calculated based on overall PM2.5 
exposure, the measure is still limited in its generalizability. PM2.5 originates from a variety 
of sources and as such equal exposure to PM from unique sources may elicit drastically 
different health effects and likely results in disparate exposure to PACs.  To fully elucidate 
the health effects of PM exposure specific biomarkers of exposure is needed, as without 
which, the identification of those at highest risk is challenging and the discovery of 
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biological signatures of susceptibility is hindered, as an accurate internal dose cannot be 
reliably calculated (Morgott, 2014). Future work will investigate the presence of 1-
nitropyrene, as well as the 16 EPA Priority PAHs to attempt to parse the contribution of 
traffic-related emissions to overall PM2.5 in this region. This work will also examine the 
relationship between measured PACs in ambient atmosphere with urinary PAC 
metabolites in an attempt to assess the utility of 1-nitropyrene urinary metabolites as 
biomarkers of TRAP.  
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